Naloxone Behind-the-Counter? Petition Could Help Push Action
This article was originally published in RPM Report
The idea of “behind-the-counter” may be behind the times, but a request to put naloxone there could help push FDA’s existing interest in expanding access to the overdose antidote.
You may also be interested in...
‘Behind-the-counter’ placement of opioid overdose treatment doesn’t resonate with agency, even as it wants to broaden availability.
A House hearing on prescription abuse highlighted a potential OTC switch: naloxone for opioid overdose.
FDA drug center chief Janet Woodcock says behind-the-counter switches would be the most effective method to make Rx drugs available without prescriptions, particularly to help treat chronic conditions.